We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$970M
AUM Growth
+$60.2M
Cap. Flow
+$2.07M
Cap. Flow %
0.21%
Top 10 Hldgs %
28.54%
Holding
185
New
9
Increased
36
Reduced
73
Closed
2

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$4.29M
2
DOX icon
Amdocs
DOX
+$1.9M
3
WPP icon
WPP
WPP
+$1.89M
4
TRMB icon
Trimble
TRMB
+$1.49M
5
PPG icon
PPG Industries
PPG
+$1.44M

Top Sells

Rank Stock Value
1
COL
Rockwell Collins
COL
+$4.32M
2
T icon
AT&T
T
+$2.51M
3
XRAY icon
Dentsply Sirona
XRAY
+$2.19M
4
MSFT icon
Microsoft
MSFT
+$1.02M
5
VOD icon
Vodafone
VOD
+$909K

Sector Composition

Rank Sector Weight
1 Technology 24.05%
2 Healthcare 17.46%
3 Financials 11.19%
4 Industrials 9.86%
5 Consumer Staples 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
101
Boeing
BA
$169B
$901K 0.09%
2,423
FAST icon
102
Fastenal
FAST
$54.8B
$898K 0.09%
61,940
-600
-1% -$8.54K
ISRG icon
103
Intuitive Surgical
ISRG
$127B
$887K 0.09%
4,638
SGEN
104
DELISTED
Seagen Inc. Common Stock
SGEN
$862K 0.09%
11,171
+95
+0.9% +$7K
SCHW
105
Charles Schwab
SCHW
$182B
$791K 0.08%
16,092
-1,000
-6% -$51.1K
NBL
106
DELISTED
Noble Energy, Inc.
NBL
$772K 0.08%
24,749
RDS.A
107
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$759K 0.08%
11,139
VV icon
108
Vanguard Large-Cap ETF
VV
$51.2B
$732K 0.08%
+5,485
New +$718K
V icon
109
Visa
V
$701B
$719K 0.07%
4,790
-436
-8% -$62K
IONS icon
110
Ionis Pharmaceuticals
IONS
$8.93B
$700K 0.07%
13,579
+110
+0.8% +$5.17K
MO icon
111
Altria Group
MO
$125B
$697K 0.07%
11,554
LLY icon
112
Eli Lilly
LLY
$1.08T
$690K 0.07%
6,425
CHX
113
DELISTED
ChampionX
CHX
$684K 0.07%
15,708
-900
-5% -$37.7K
CSX icon
114
CSX Corp
CSX
$94B
$681K 0.07%
27,600
AMZN icon
115
Amazon
AMZN
$2.44T
$671K 0.07%
6,700
ABBV icon
116
AbbVie
ABBV
$465B
$658K 0.07%
6,961
-1,093
-14% -$104K
BMRN icon
117
BioMarin Pharmaceuticals
BMRN
$11.9B
$646K 0.07%
6,662
+70
+1% +$6.99K
GLD icon
118
SPDR Gold Trust
GLD
$131B
$646K 0.07%
5,727
FUL icon
119
H.B. Fuller
FUL
$3B
$625K 0.06%
12,094
SLB icon
120
SLB Ltd
SLB
$72.7B
$621K 0.06%
10,198
FISV
121
Fiserv Inc
FISV
$29.7B
$581K 0.06%
7,048
J icon
122
Jacobs Solutions
J
$16B
$578K 0.06%
9,134
VEU icon
123
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$573K 0.06%
11,000
INCY icon
124
Incyte
INCY
$25.4B
$550K 0.06%
7,968
+75
+1% +$5.15K
ALXN
125
DELISTED
Alexion Pharmaceuticals
ALXN
$539K 0.06%
3,880
+35
+0.9% +$4.39K

Similar funds

Grandfield & Dodd's Q3 2018 Portfolio in Review

As of Q3 2018, Grandfield & Dodd held 185 positions worth $970M, up 6.6% from $910M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Grandfield & Dodd's Q3 2018 filing shows 9 new, 36 increased, 73 reduced and 2 closed positions. Its largest new stake was Vanguard Large-Cap ETF: 5,485 shares worth $732K. The largest sale was Rockwell Collins, an estimated $4.32M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Grandfield & Dodd's largest Q3 2018 buy was Vanguard Large-Cap ETF: 5,485 shares worth $732K.
  • Grandfield & Dodd added most to Chubb in Q3 2018, an estimated $4.29M increase.
  • Grandfield & Dodd's biggest Q3 2018 reduction was Rockwell Collins, cutting an estimated $4.32M.
  • Grandfield & Dodd fully exited Keurig Dr Pepper in Q3 2018, selling an estimated $423K.
  • Grandfield & Dodd's ten largest holdings make up 29% of its $970M portfolio in Q3 2018.
  • Grandfield & Dodd opened 9 new positions and closed 2 in Q3 2018.
  • Grandfield & Dodd's portfolio value rose 6.6% quarter-over-quarter to $970M.

Based on Grandfield & Dodd's 13F filing for Q3 2018, filed 2 Nov 2018.